Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Transition Metal Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-step catalytic method for tetrahydrophenazine derivatives using nitroanilines and diphenols. Offers high atom economy and scalable production for pharmaceutical and electronic applications.
Patent CN111689883B reveals a novel copper-catalyzed route for diaryl sulfones. This method offers mild conditions, air oxidation, and significant cost reduction potential.
Novel cobalt-catalyzed synthesis of Paxlovid key intermediate offers safer, shorter routes with reduced waste for reliable pharmaceutical intermediate supply chains.
Patent CN114644587A details a novel 3-step synthesis for Paxlovid's bicyclic imine intermediate, offering safer processing and cost reduction in API manufacturing.
Novel one-step synthesis of quinolines from nitro alcohol and alcohol. Reduces steps, enhances supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN114716356A details a green Rh-catalyzed route for isothiocyanates, offering safer alternatives to thiophosgene and improved supply chain reliability for fine chemical manufacturing.
Patent CN112300151B enables efficient Maropitant intermediate production. Reduced steps and high ee value ensure cost reduction in pharmaceutical manufacturing.
Novel copper-catalyzed route for 2-azabicyclo[3.2.0] intermediates offers mild conditions and high yields, ensuring reliable supply chain solutions.
Advanced catalytic process for NEP inhibitor intermediates offering superior stereoselectivity. Discover cost-effective manufacturing solutions for complex amino acid derivatives.
Patent CN106045883A reveals a novel metal-chelation route for Fmoc-Asp-OtBu, offering significant cost reduction and enhanced supply chain reliability for peptide synthesis.
Patent CN108129308A introduces visible light catalysis for ester synthesis offering green supply chain and cost advantages for pharmaceutical intermediate manufacturing processes globally.
Patent CN109912487B reveals a novel non-transition metal catalytic route for high-purity pharmaceutical intermediates, offering significant supply chain and cost advantages.
Patent CN109180592B details a green synthesis of 7-chloro-2-(3-chlorophenyl)quinazoline using NNN-Ru catalysts. Discover cost-effective, scalable manufacturing solutions.
Novel Rh-catalyzed borylation method for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for complex chiral building blocks.
Novel 2,3'-bisfuran synthesis patent CN115073401B enables cost-effective production of fluorescent materials with improved supply chain reliability for electronic applications.
Patent CN103242372B reveals efficient iridium adducts for aryl ketone synthesis. Enables cost reduction and scalable supply chain for pharmaceutical intermediates.
Patent CN111302990A reveals a mild Pd-catalyzed radical alkenylation for conjugated dienes, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110015981B details a CuI-catalyzed three-component synthesis of functionalized thioethers. This method offers mild conditions, high yields, and significant cost reduction in pharmaceutical manufacturing.
Patent CN110015981B details a novel CuI-catalyzed three-component reaction for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable manufacturing.
Patent CN109970789B reveals a metal-free route for triarylphosphine intermediates, offering significant cost reduction and simplified purification for pharmaceutical manufacturing.